This is the authors' abstract. We don't add key points for this paper.
This article studies the binding of the antitumor drug doxorubicin (DOX) with the nanocluster polyoxometalate (POM) {Mo 72 Fe 30 }, the latter serving as the drug carrier. The formation of a stoichiometric complex POM@(DOX) 12 was observed in aqueous media. Using the Stern‐Volmer technique, we found the binding constant and free Gibbs energy for this interaction. The produced complex POM@(DOX) 12 was examined with ultraviolet‐visible (UV‐Vis), fluorescence (steady state and life‐time), infrared (IR) and X‐ray photoelectron spectroscopy (XPS), which revealed the stoichiometry of complex and a key role of {Mo 3 Fe 3 } host pores on the POM surface to DOX binding. DOX's ability to intercalate into DNA after binding with the {Mo 72 Fe 30 } was investigated using a pH typical for blood (7.4). A pH‐dependent release of DOX from POM@(DOX) 12 was demonstrated (rate constant is 3.3×10 −4 s −1 ). Finally, we showed that the immobilization of doxorubicin on the POM's surface can reduce undesired side effects.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Тонкушина et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: